#1 Clinical Trials Search in Europe

Pyrimethamine

Pyrimethamine, a medication traditionally used to treat malaria and toxoplasmosis, is currently being studied in clinical trials for its potential in treating a variety of medical conditions. These trials are exploring the drug’s effectiveness in areas such as cancer treatment, neurodegenerative diseases, and autoimmune disorders. This article provides an overview of the ongoing research into pyrimethamine’s diverse applications in medicine.

Table of Contents

What is Pyrimethamine?

Pyrimethamine, also known by the brand name Daraprim, is an FDA-approved medication that has been used for decades to treat various conditions[1]. It’s primarily known for its effectiveness against certain parasitic infections, but recent research has explored its potential in treating other diseases as well.

Uses of Pyrimethamine

Pyrimethamine is used to treat or prevent several conditions:

  • Malaria and Toxoplasmosis: Pyrimethamine is traditionally used to treat or prevent these parasitic infections[2].
  • Toxoplasmic Encephalitis in HIV Patients: It’s used to prevent and treat brain inflammation caused by the Toxoplasma parasite in people with HIV[2].
  • Malaria Prevention in Pregnancy: When combined with sulfadoxine, pyrimethamine is used to prevent malaria in pregnant women[3].

Ongoing research is exploring its potential in treating:

  • Autoimmune Lymphoproliferative Syndrome (ALPS): A rare genetic disorder affecting the immune system[4].
  • Familial Amyotrophic Lateral Sclerosis (FALS): A genetic form of ALS, a progressive neurological disease[1].
  • GM2 Gangliosidosis: Including Tay-Sachs and Sandhoff diseases, which are rare genetic disorders affecting the nervous system[5].
  • Certain Types of Cancer: Including chronic lymphocytic leukemia and head and neck cancer[6][7].

How Pyrimethamine Works

Pyrimethamine works in different ways depending on the condition it’s treating:

  • For parasitic infections, it inhibits an enzyme that the parasites need to survive[2].
  • In FALS, it may reduce levels of a protein called SOD1, which is thought to contribute to the disease[1].
  • In GM2 Gangliosidosis, it may help stabilize and improve the function of an important enzyme[5].
  • In cancer research, it’s being studied for its potential to inhibit certain proteins that may contribute to tumor growth[7].

Administration and Dosage

Pyrimethamine is typically taken orally (by mouth) as a tablet. The dosage and frequency can vary greatly depending on the condition being treated and the individual patient. For example:

  • For malaria prevention in pregnancy, it may be taken monthly or twice during pregnancy[3].
  • In cancer studies, doses have ranged from 12.5 mg to 150 mg daily[6].
  • For FALS, doses started at 25 mg and increased gradually[1].

It’s crucial to follow your doctor’s instructions precisely when taking pyrimethamine.

Potential Side Effects

Like all medications, pyrimethamine can cause side effects. Some potential side effects include:

  • Bone marrow suppression, which can affect blood cell production[1].
  • Skin rashes or mouth sores[4].
  • Gastrointestinal issues

Your doctor may monitor you closely and may prescribe supplements like folinic acid to help manage potential side effects[4].

Ongoing Research

Pyrimethamine is being studied in several clinical trials for various conditions:

  • Its potential to slow the progression of FALS by reducing SOD1 levels[1].
  • Its ability to improve enzyme function in GM2 Gangliosidosis[5].
  • Its potential as a cancer treatment, particularly for certain types of leukemia and head and neck cancers[6][7].

Precautions and Considerations

When taking pyrimethamine, it’s important to keep in mind:

  • Pregnancy: Pyrimethamine can cause birth defects if taken during early pregnancy[4]. Women who can become pregnant should use effective birth control while taking this medication.
  • Regular monitoring: Your doctor may require regular blood tests to check for potential side effects[1].
  • Drug interactions: Pyrimethamine can interact with other medications. Always inform your doctor about all medications and supplements you’re taking.
  • Long-term use: Some studies are exploring long-term use of pyrimethamine for certain conditions. This should only be done under close medical supervision[6].

Remember, pyrimethamine is a powerful medication that should only be taken under the guidance of a healthcare professional. Never start, stop, or change the dosage of this medication without consulting your doctor first.

Condition Study Phase Dosage Key Findings/Objectives
Head and Neck Cancer Early Phase I 50 mg daily for 14 days Investigating pyrimethamine as an NRF2 inhibitor
Myelodysplastic Syndromes (MDS) Phase I 50-150 mg daily, dose escalation Assessing safety, dose tolerance, and efficacy in refractory/relapsed MDS
Chronic Lymphocytic Leukemia Phase I/II 12.5-50 mg daily Evaluating safety and efficacy in relapsed CLL/SLL
Familial ALS Phase I/II Dose escalating Assessing safety and effect on SOD1 levels
GM2 Gangliosidosis Phase I Dose escalation from 6.25-37.5 mg/day Evaluating safety and potential to restore brain function
Autoimmune Lymphoproliferative Syndrome Phase I-II Weight-based, escalating doses Assessing effect on lymph node and spleen size

FAQ

  • What is pyrimethamine and what is it traditionally used for? Pyrimethamine is an antibiotic medication that has been traditionally used to treat or prevent malaria and toxoplasmosis. It is also known by the brand name Daraprim.
  • What new medical conditions are being studied for pyrimethamine treatment? Clinical trials are exploring pyrimethamine's potential in treating various conditions, including certain types of cancer (like head and neck cancer and chronic lymphocytic leukemia), neurodegenerative diseases (such as ALS and GM2 gangliosidosis), and autoimmune disorders (like autoimmune lymphoproliferative syndrome).
  • How does pyrimethamine work in cancer treatment? In cancer treatment, pyrimethamine is being studied for its ability to inhibit certain proteins or enzymes that may contribute to tumor growth. For example, in head and neck cancer, it's being investigated as an inhibitor of NRF2, a protein involved in tumor progression and treatment resistance.
  • Are there any potential side effects of pyrimethamine? Like all medications, pyrimethamine can have side effects. In the clinical trials, researchers are closely monitoring for adverse events, which may include bone marrow toxicity. Some studies are using folinic acid supplementation to help manage potential side effects.
  • How is pyrimethamine administered in these clinical trials? In most of the trials, pyrimethamine is administered orally, with dosages and frequency varying depending on the specific study and condition being treated. Some trials use a dose-escalation approach to determine the optimal dosage.

Ongoing Clinical Trials on Pyrimethamine

  • A study to evaluate the effectiveness of lenalidomide, pyrimethamine, and topiramate in reducing the HIV reservoir in people living with HIV.

    Not yet recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

  • Study on Reversing HIV Latency Using Pyrimethamine, Lenalidomide, and Panobinostat for People Living with HIV

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands

Glossary

  • Pyrimethamine: An antibiotic medication traditionally used to treat malaria and toxoplasmosis, now being studied for its potential in treating various other medical conditions.
  • NRF2: A protein involved in tumor progression and treatment resistance in some cancers, which pyrimethamine is being studied to inhibit.
  • STAT3: A protein that may be important for the growth of certain cancer cells, which pyrimethamine may target in some studies.
  • Amyotrophic Lateral Sclerosis (ALS): A neurodegenerative disease causing progressive weakness of the arms, legs, and respiratory muscles, for which pyrimethamine is being studied as a potential treatment.
  • GM2 Gangliosidosis: A group of inherited disorders that progressively destroy nerve cells in the brain and spinal cord, including Tay-Sachs and Sandhoff diseases, which are being studied for treatment with pyrimethamine.
  • Autoimmune Lymphoproliferative Syndrome (ALPS): An inherited disorder of the immune system characterized by abnormal growth of lymphocytes and autoimmune problems, for which pyrimethamine is being investigated as a treatment.
  • Myelodysplastic Syndromes (MDS): A group of disorders caused by poorly formed or dysfunctional blood cells, which is being studied for treatment with pyrimethamine.
  • Intermittent Preventive Treatment (IPT): A public health intervention to prevent malaria in pregnant women, infants, and children, which often involves the use of pyrimethamine in combination with other drugs.
  • Folinic Acid: A form of folic acid sometimes used in conjunction with pyrimethamine to help manage potential side effects, particularly bone marrow toxicity.
  • Dose-Escalation: A method used in clinical trials where the dose of a drug is gradually increased to determine the optimal dosage that balances effectiveness and safety.

References

  1. https://clinicaltrials.gov/study/NCT01083667
  2. https://clinicaltrials.gov/study/NCT00000666
  3. https://clinicaltrials.gov/study/NCT03599596
  4. https://clinicaltrials.gov/study/NCT00065390
  5. https://clinicaltrials.gov/study/NCT00679744
  6. https://clinicaltrials.gov/study/NCT01066663
  7. https://clinicaltrials.gov/study/NCT05678348